Immunic
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -31 | -26 | -23 | |
EBITDA | -25,684 | -22,783 | -23,855 | -23,358 |
EBIT | -25,726 | -22,814 | -23,881 | -23,381 |
Net Income | -24,368 | -21,380 | -29,584 | -21,572 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -20,853 | -17,211 | -24,000 | -14,192 |
Cash | 59,071 | 79,698 | 97,312 | 46,674 |
Basic Shares | 101,272 | 101,272 | 97,299 | 44,632 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -111 | -77 | -85 | -39 |
EBITDA | -99,112 | -120,330 | -91,580 | -48,932 |
EBIT | -99,223 | -120,407 | -91,665 | -48,971 |
Net Income | -93,612 | -154,296 | -92,794 | -43,959 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Cost of Revenue | 20,875 | -40,459 | 98,161 | |
Free Cash Flow | -71,162 | -65,256 | -83,300 | -46,270 |
Cash | 46,674 | 106,745 | 86,863 | 127,452 |
Basic Shares | 44,320 | 31,819 | 23,652 | 15,663 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$0.24 |
2024-06-30 | -$0.21 |
2024-03-31 | -$0.30 |
2023-12-31 | -$0.48 |
